- Livongo reports Q2 19 total revenue of $40.9 million, up 156% year-over-year- 192,934 enrolled Livongo for Diabetes Members, up 140% year-over-year with 38,170 new Livongo for Diabetes Members in Q2- Total Contract Value of $74.2 million, up from $24.8 million in the second quarter of 2018. Livongo Health, Inc. (NASDAQ: LVGO), an Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced financial results for its second quarter
Read More
Livongo Health |Applied Health Signals | Digital Health Management for Chronic Conditions | News, Analysis - HIT Consultant
Livongo Founder Glen Tullman to Receive “Ripple of Hope” Award
Livongo Founder and Executive Chairman Glen Tullman will be honored with a Robert F. Kennedy Human Rights Ripple of Hope Award for his career focused on improving the safety, empathy, and efficiency of our healthcare system.
The Ripple of Hope Award Background
The Ripple of Hope Award celebrates leaders of the international business, entertainment, and activist communities who have demonstrated a commitment to social change. Past honorees include President Barack Obama, Archbishop
Read More
Livongo to Offer 10.7 Million Shares in IPO, Priced Between $20 & $23 Per Share
Livongo Health, Inc., today announced it plans to offer 10,700,000 shares of its common stock to the public with the price expected to be between $20.00 and $23.00 per share. Livongo has applied to list its common stock on the Nasdaq Global Select Market under the symbol “LVGO.” Livongo also intends to grant the underwriters a 30-day option to purchase up to an additional 1,605,000 shares of common stock from Livongo.Livongo offers an integrated suite of solutions to promote sustainable health
Read More
Digital Health Company Livongo Files for $100M IPO
Livongo Health, Inc., today announced that it has publicly filed a registration statement for a proposed initial public offering (IPO) of its common stock, according to the U.S. Securities and Exchange Commission (SEC) filing. Livongo has applied to list its common stock on the Nasdaq Global Select Market under the ticker symbol "LVGO."Livongo Growth MetricsFounded in 2014, Livongo offers an integrated suite of solutions to promote sustainable health behavior change based on easy, real-time data
Read More
CMS Approves Livongo As An Enrolled Provider for Medicare Advantage Members
Livongo, the leading Applied Health Signals company announced that it has been approved by the Centers for Medicare and Medicaid Services (CMS) as an enrolled provider for Medicare Advantage members. In addition, starting in June, the Livongo for Diabetes program will be available to Medicare Advantage members of Cambia Health Solutions' regional health plans.Empowering America's Senior PopulationCambia reaches nearly 70 million Americans nationwide, including more than two million people in the
Read More
Mercom: Global Digital Health/Health IT VC Funding Tops $2B in Q1 2019
Global venture capital (VC) funding in digital health/health IT, including private equity and corporate venture capital, reach $2 billion in funding in Q1 2019, according to market research firm Mercom Capital. The Q1 2019 Digital Health (Healthcare IT) Funding and M&A Report reveals $2B in funding across 149 deals compared to $1.4B across 142 deals in Q4 2018. VC funding in Q1 2019 was down 19% compared to the same quarter of last year (Q1 2018) when nearly $2.5 billion was raised in 187
Read More
March 2019 News, Merger & Acquisition, IPO, Public Company Performance Summary
A brief summary of noteworthy news, health IT M&A activity, IPOs, and public company performance during the month of March.
Noteworthy News
Amazon, JP Morgan, Berkshire Names New Joint Venture Haven
Amazon, J.P. Morgan, and Berkshire Hathaway name joint venture Haven. In January 2018, the three founding companies announced plans to create this independent organization, now called Haven, which is free from profit-making incentives and constraints. Haven’s focus is the 1.2 million
Read More
Livongo Adds HIPAA-Compliant Amazon Alexa Healthcare Skill for Diabetes
Livongo, the leading Applied Health Signals company, today announced the Livongo for Diabetes program will now leverage Amazon Alexa's voice service to offer its Members the ability to ask any of their Alexa-enabled devices to provide their blood glucose readings and health tips via the new Livongo skill. The integration marks Livongo as the first consumer digital health company to collaborate with Amazon Alexa on a new HIPAA-compliant healthcare skill, which builds on Livongo's efforts to make
Read More
Livongo Taps Amazon Lex to Power Voice-Enabled Hypertension System
Livongo unveils new voice-enabled cellular blood pressure monitoring system powered by Amazon Lex and Amazon PollyApplied health signals company Livongo Health, today unveiled their new voice-enabled hypertension system powered by Amazon during their invitation-only conference SIGNUM 2019 in San Francisco, CA. As voice increasingly becomes one of the preferred ways people interact with technology, Livongo will leverage Amazon Lex and Amazon Polly to power its voice-enabled cellular blood
Read More
Livongo Acquires Digital Behavioral Health Solution myStrength
Livongo Health, an Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that it has acquired Denver-based myStrength, Inc., a provider of digital behavioral health solutions. Financial terms of the acquisition were not disclosed. The acquisition enables Livongo to more fully address the health of the whole person by integrating behavioral health conditions including depression, anxiety, stress, substance use disorder,
Read More
